Previous
G-1072
Pneumovax 23
Next
G-13533-131-01
TDVAX Tetanus and Diphtheria Toxoids Adsorbed 0.5 mL SDV
VAQTA (Hepatitis A Vaccine Inactivated) Adult Single-Dose 1-mL Syringes
SKU
G-0006-4096-02-01
Physician's authorization is required to purchase this item.
VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.
VAQTA is available in prefilled Luer-Lok® syringes.
Adult formulations
Prefilled Luer-Lok®syringes
| Image | SKU | Product Name | Packaging | Availability | Price | Add To cart |
|---|---|---|---|---|---|---|
 | 0006-4096-02 | VAQTA (Hepatitis A Vaccine Inactivated) Adult 1 mL SDV | 10/BX | 5-10 Days |
$1,099.90
|
More from Merck
Who Bought This Also Bought
